Cargando…

Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients

INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Almaeen, Abdulrahman Hamdan, Alduraywish, Abdulrahman Abdulwahab, Mobasher, Maysa Ahmed, Almadhi, Omar I. M., Nafeh, Hanan M., El-Metwally, Tarek Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959056/
https://www.ncbi.nlm.nih.gov/pubmed/33747272
http://dx.doi.org/10.5114/aoms.2019.91451
_version_ 1783664904747614208
author Almaeen, Abdulrahman Hamdan
Alduraywish, Abdulrahman Abdulwahab
Mobasher, Maysa Ahmed
Almadhi, Omar I. M.
Nafeh, Hanan M.
El-Metwally, Tarek Hassan
author_facet Almaeen, Abdulrahman Hamdan
Alduraywish, Abdulrahman Abdulwahab
Mobasher, Maysa Ahmed
Almadhi, Omar I. M.
Nafeh, Hanan M.
El-Metwally, Tarek Hassan
author_sort Almaeen, Abdulrahman Hamdan
collection PubMed
description INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MATERIAL AND METHODS: This cross-sectional study aimed to evaluate the changes in blood oxidative stress, cellular hypoxia/angiogenesis and cellular immunological biomarkers in hospital-diagnosed treatment-naïve HCV-infected Upper Egyptian chronic liver disease patients vs. healthy controls (n = 40). The consecutively included patients comprised 120 with normal serum enzymes (HCV-NE) and 130 with high serum enzymes (HCV-HE), along with 120 cirrhotic patients. RESULTS: Oxidative stress biomarkers – malondialdehyde (MDA), total peroxides and oxidative stress index (OSI) – were significantly lower in controls vs. each of the patient groups. Cirrhotic patients presented the highest levels. However, total antioxidants (TAO) showed non-significant differences among the four groups. The cellular hypoxia/angiogenesis biomarkers – lactate, vascular endothelial cell growth factor (VEGF) and its soluble receptor 1 (sVEGFR1) – vs. controls were massively increased in patient groups. VEGF was lowest while sVEGFR1 was highest among cirrhotic patients. Immunological biomarkers, – granulocyte/monocyte-colony stimulating factor (GM-CSF) and total immunoglobulin G (IgG) – were massively increased in patient groups vs. controls. GM-CSF was lowest in HCV-HE and IgG was highest in cirrhotic patients. sVEGFR1 correlated with the progression towards cirrhosis. CONCLUSIONS: Oxidative stress is implicated in the progress of HCV infection with marked induction of cellular hypoxia and dysfunctional angiogenesis, and a futile immunological reaction. sVEGFR1 level correlated with progression towards HCV-induced liver fibrosis.
format Online
Article
Text
id pubmed-7959056
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-79590562021-03-19 Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients Almaeen, Abdulrahman Hamdan Alduraywish, Abdulrahman Abdulwahab Mobasher, Maysa Ahmed Almadhi, Omar I. M. Nafeh, Hanan M. El-Metwally, Tarek Hassan Arch Med Sci Clinical Research INTRODUCTION: Hepatitis C virus (HCV) is the main cause of chronic liver disease, with calamitous complications. Its highest rate is recorded in Egypt. This study investigated whether oxidative stress, immunological chaos and cellular hypoxia are implicated in the pathophysiology of the disease. MATERIAL AND METHODS: This cross-sectional study aimed to evaluate the changes in blood oxidative stress, cellular hypoxia/angiogenesis and cellular immunological biomarkers in hospital-diagnosed treatment-naïve HCV-infected Upper Egyptian chronic liver disease patients vs. healthy controls (n = 40). The consecutively included patients comprised 120 with normal serum enzymes (HCV-NE) and 130 with high serum enzymes (HCV-HE), along with 120 cirrhotic patients. RESULTS: Oxidative stress biomarkers – malondialdehyde (MDA), total peroxides and oxidative stress index (OSI) – were significantly lower in controls vs. each of the patient groups. Cirrhotic patients presented the highest levels. However, total antioxidants (TAO) showed non-significant differences among the four groups. The cellular hypoxia/angiogenesis biomarkers – lactate, vascular endothelial cell growth factor (VEGF) and its soluble receptor 1 (sVEGFR1) – vs. controls were massively increased in patient groups. VEGF was lowest while sVEGFR1 was highest among cirrhotic patients. Immunological biomarkers, – granulocyte/monocyte-colony stimulating factor (GM-CSF) and total immunoglobulin G (IgG) – were massively increased in patient groups vs. controls. GM-CSF was lowest in HCV-HE and IgG was highest in cirrhotic patients. sVEGFR1 correlated with the progression towards cirrhosis. CONCLUSIONS: Oxidative stress is implicated in the progress of HCV infection with marked induction of cellular hypoxia and dysfunctional angiogenesis, and a futile immunological reaction. sVEGFR1 level correlated with progression towards HCV-induced liver fibrosis. Termedia Publishing House 2020-01-03 /pmc/articles/PMC7959056/ /pubmed/33747272 http://dx.doi.org/10.5114/aoms.2019.91451 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Almaeen, Abdulrahman Hamdan
Alduraywish, Abdulrahman Abdulwahab
Mobasher, Maysa Ahmed
Almadhi, Omar I. M.
Nafeh, Hanan M.
El-Metwally, Tarek Hassan
Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title_full Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title_fullStr Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title_full_unstemmed Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title_short Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients
title_sort oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis c treatment-naïve and cirrhotic patients
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959056/
https://www.ncbi.nlm.nih.gov/pubmed/33747272
http://dx.doi.org/10.5114/aoms.2019.91451
work_keys_str_mv AT almaeenabdulrahmanhamdan oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients
AT alduraywishabdulrahmanabdulwahab oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients
AT mobashermaysaahmed oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients
AT almadhiomarim oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients
AT nafehhananm oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients
AT elmetwallytarekhassan oxidativestressimmunologicalandcellularhypoxiabiomarkersinhepatitisctreatmentnaiveandcirrhoticpatients